Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Secuado (asenapine) for the Treatment of Schizophrenia

Drug Name

Secuado® (asenapine)

Developer

Hisamitsu Pharmaceutical

Therapy Class

Atypical antipsychotics

Product Description

Dopamine (D2) and 5-HT2A receptors antagonist

Current Indication

Schizophrenia

Market Sector

CNS

Development Status

Approved in the US
Expand
Close
Close
Close

Go Top